Results 11 to 20 of about 55,959 (291)

Incidence of QT interval prolongation during arsenic trioxide-based therapy in a sample of Iraqi adult patients with acute promyelocytic leukemia (a single-center experience)

open access: diamondIraqi Journal of Hematology
BACKGROUND: Arsenic trioxide (ATO) regimen is now the standard of care for acute promyelocytic leukemia (APL). The complete remission and possible cure are reported to be 50%–80% of APL patients.
Aseel Abd Ul Sahib Hassan   +1 more
doaj   +2 more sources

Serial electrocardiogram recordings revealed a high prevalence of QT interval prolongation in patients with tuberculosis receiving fluoroquinolones

open access: yesJournal of the Formosan Medical Association, 2023
Background: Fluoroquinolones, crucial components of treatment regimens for drug-resistant tuberculosis (TB), are associated with QT interval prolongation and risks of fatal cardiac arrhythmias. However, few studies have explored dynamic changes in the QT
Ke-Shiuan Ju   +8 more
doaj   +1 more source

The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients

open access: yesCardiovascular Drugs and Therapy, 2023
Introduction Drug-induced QT interval prolongation has been reported to be related to life-threatening polymorphic ventricular tachycardia (torsade de pointes).
Weiguo Fan   +3 more
semanticscholar   +1 more source

Hypocalcemia-Induced QT Interval Prolongation

open access: yesThe Cardiology, 2022
An 87-year-old man with a history of transcatheter aortic valve replacement, pulmonary hypertension, diastolic dysfunction with preserved systolic function, and myelofibrosis had a 12-lead ECG showed a prolonged QT interval of 508 ms with heart-rate ...
J. K. Tang, S. Rabkin
semanticscholar   +1 more source

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients

open access: yesCardiovascular Therapeutics, 2021
Background Hydroxychloroquine with or without azithromycin was one of the common therapies at the beginning of the COVID-19 pandemic. They can prolong QT interval, cause torsade de pointes, and lead to sudden cardiac death. We aimed to assess QT interval
S. P. Eftekhar   +5 more
semanticscholar   +1 more source

Bedaquiline Correlation to QT Interval Prolongation in DR-TB Patients

open access: yesJurnal Respirasi, 2022
Introduction: The regimen of drug-resistant tuberculosis (DR-TB) is Bedaquiline. One of the adverse events is QT interval prolongation, which can increase the risk of Torsade de Pointes (TdP) and lead to death. DR-TB patient screening before starting the
Vandu Primadana   +2 more
doaj   +1 more source

Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm

open access: yesAmerican Journal of Transplantation, 2021
It is postulated that cardiac structural abnormalities observed in cirrhotic cardiomyopathy (CCM) contribute to the electrophysiologic abnormality of QT interval (QTc) prolongation.
A. Koshy   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy